RxDoctor Payments DataLook up a doctor →

Mycophenolate Mofetil: payments to doctors

Payments that named Mycophenolate Mofetil as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$20K
Providers
4
Transactions
44
Average per transaction
$462

The per-transaction average — $462 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4 providers the average total is $5,083, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Amneal Pharmaceuticals LLC$8,21740.4%
Akorn, Inc.$5,70028.0%
Mylan Inc.$3,08315.2%
Hikma Pharmaceuticals USA$2,72013.4%
Sandoz$4772.3%
Mylan Specialty L.p.$1330.7%
← All drugs & devices